Airway dysbiosis accelerates lung function decline in chronic obstructive pulmonary disease

Weijie Liang,Yuqiong Yang,Shenhai Gong,Mingyuan Wei,Yingfei Ma,Ruipei Feng,Jingyuan Gao,Xiaomin Liu,Fuyi Tu,Wei Ma,Xinzhu Yi,Zhenyu Liang,Fengyan Wang,Lingwei Wang,Dandan Chen,Wensheng Shu,Ruth Tal-Singer,Dave Singh,Rongchang Chen,Nanshan Zhong,Zhang Wang,Bruce E. Miller,Gavin C. Donaldson,Jadwiga A. Wedzicha,Tom M.A. Wilkinson,Christopher E. Brightling

DOI: https://doi.org/10.1016/j.chom.2023.04.018

IF: 31.316

2023-05-01

Cell Host & Microbe

Abstract:Progressive lung function decline is a hallmark of chronic obstructive pulmonary disease (COPD). Airway dysbiosis occurs in COPD, but whether it contributes to disease progression remains unknown. Here, we show, through a longitudinal analysis of two cohorts involving four UK centers, that baseline airway dysbiosis in COPD patients, characterized by the enrichment of opportunistic pathogenic taxa, associates with a rapid forced expiratory volume in 1 s (FEV₁) decline over 2 years. Dysbiosis associates with exacerbation-related FEV₁ fall and sudden FEV₁ fall at stability, contributing to long-term FEV₁ decline. A third cohort in China further validates the microbiota-FEV₁-decline association. Human multi-omics and murine studies show that airway Staphylococcus aureus colonization promotes lung function decline through homocysteine, which elicits a neutrophil apoptosis-to-NETosis shift via the AKT1-S100A8/A9 axis. S. aureus depletion via bacteriophages restores lung function in emphysema mice, providing a fresh approach to slow COPD progression by targeting the airway microbiome.

microbiology,virology,parasitology